Summit buys microkeratome from EyeTech Vision
This article was originally published in Clinica
Ophthalmic laser company Summit Technology has bought the Krumeich-Barraquer microkeratome from EyeTech Vision, which is based in Liechtenstein and the US, for an undisclosed sum. Summit will begin selling the high precision, corneal surgical device to international customers immediately. The Waltham, Massachusetts-based company will commence sales in the US upon receipt of FDA 510(k) clearance.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.